New York Oncology Hematology

NewYork Oncology Hematology is a medical practice that specializes in the diagnosis, treatment, and ongoing management of cancer and blood disorders. The organization provides oncology and hematology services to patients residing in the United States, with its headquarters situated in the United States of America. As a specialty provider, it offers a range of therapeutic interventions that may include chemotherapy, immunotherapy, targeted therapy, and supportive care aimed at alleviating symptoms and improving quality of life for individuals with malignant conditions. In addition to cancer care, the practice addresses hematologic diseases such as anemia, coagulation disorders, and malignancies of the blood through diagnostic testing, therapeutic infusions, and monitoring services. The organization serves a diverse patient population that includes individuals seeking both outpatient consultations and inpatient‑related follow‑up, and it works alongside other healthcare professionals to deliver coordinated, multidisciplinary treatment plans. Its focus on oncology and hematology positions it within the broader healthcare sector as a provider of specialized medical expertise that requires adherence to stringent clinical standards and patient safety protocols. By concentrating on these two interconnected fields, the practice contributes to the advancement of care pathways that integrate medical oncology, hematology, and supportive services.

In April 2018, the organization experienced a phishing attack in which deceptive login pages compromised the credentials of 14 employee email accounts, leading to a precautionary notification to more than 128,400 patients and employees whose protected health information or personal details might have been present in the affected accounts. Although a forensic investigation found no evidence that the attackers actually accessed or misused any data, the incident prompted the organization to enforce immediate password resets and to implement additional account security measures such as multi‑factor authentication. The notification process specifically excluded individuals who had joined the organization after the attack period, ensuring that only those potentially exposed during the window were informed. This event underscored the organization’s responsibility to safeguard sensitive health data and highlighted the importance of robust cybersecurity defenses within a healthcare setting.